Abstract

The single nucleotide polymorphism (SNP) rs744373 in the bridging integrator-1 gene (BIN1) is a risk factor for Alzheimer’s disease (AD). In the brain, BIN1 is involved in endocytosis and sustaining cytoskeleton integrity. Post-mortem and in vitro studies suggest that BIN1-associated AD risk is mediated by increased tau pathology but whether rs744373 is associated with increased tau pathology in vivo is unknown. Here we find in 89 older individuals without dementia, that BIN1 rs744373 risk-allele carriers show higher AV1451 tau-PET across brain regions corresponding to Braak stages II–VI. In contrast, the BIN1 rs744373 SNP was not associated with AV45 amyloid-PET uptake. Furthermore, the rs744373 risk-allele was associated with worse memory performance, mediated by increased global tau levels. Together, our findings suggest that the BIN1 rs744373 SNP is associated with increased tau but not beta-amyloid pathology, suggesting that alterations in BIN1 may contribute to memory deficits via increased tau pathology.

Highlights

  • The single nucleotide polymorphism (SNP) rs744373 in the bridging integrator-1 gene (BIN1) is a risk factor for Alzheimer’s disease (AD)

  • The genotype of the BIN1 rs744373 SNP was extracted from Alzheimer’s Disease Neuroimaging Initiative (ADNI) genome-wide association studies (GWAS) data provided by the ADNI genetics core, where we found 22 cognitively normal (CN) subjects and 18 mild cognitively impaired (MCI) subjects to carry at least one copy of the BIN1 rs744373 G-allele which confers higher risk of AD dementia as shown by GWAS4

  • Supporting our hypothesis, we found that the BIN1 rs744373 riskallele was significantly associated with worse ADNI-MEM scores (β = −0.25, p = 0.030), where this association was mediated via global AV1451 tau-PET uptake

Read more

Summary

Introduction

The single nucleotide polymorphism (SNP) rs744373 in the bridging integrator-1 gene (BIN1) is a risk factor for Alzheimer’s disease (AD). We find in 89 older individuals without dementia, that BIN1 rs744373 risk-allele carriers show higher AV1451 tau-PET across brain regions corresponding to Braak stages II–VI. Recent genome-wide association studies (GWAS) have identified several loci that are associated with increased risk of AD, among which the single nucleotide polymorphisms (SNPs) in the bridging integrator 1 (BIN1) gene show the second highest oddsratios for sporadic AD, superseded only by apolipoprotein E (APOE) variants[3,4,5,6,7]. In post-mortem studies in AD, higher brain BIN1 expression was found to be associated with the presence of neurofibrillary tau tangles[16].

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call